Trial Profile
A Long-term Open-label Study of DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension -Phase 3-
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jun 2015
Price :
$35
*
At a glance
- Drugs Tafluprost/timolol (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Registrational; Therapeutic Use
- Sponsors Santen Pharmaceutical
- 24 Apr 2014 New trial record